Bioprinted research models of urological malignancy
Open Access
- 20 February 2024
- journal article
- review article
- Published by Wiley in Exploration
- Vol. 4 (4) , 20230126
Abstract
Urological malignancy (UM) is among the leading threats to health care worldwide. Recent years have seen much investment in fundamental UM research, including mechanistic investigation, early diagnosis, immunotherapy, and nanomedicine. However, the results are not fully satisfactory. Bioprinted research models (BRMs) with programmed spatial structures and functions can serve as powerful research tools and are likely to disrupt traditional UM research paradigms. Herein, a comprehensive review of BRMs of UM is presented. It begins with a brief introduction and comparison of existing UM research models, emphasizing the advantages of BRMs, such as modeling real tissues and organs. Six kinds of mainstream bioprinting techniques used to fabricate such BRMs are summarized with examples. Thereafter, research advances in the applications of UM BRMs, such as culturing tumor spheroids and organoids, modeling cancer metastasis, mimicking the tumor microenvironment, constructing organ chips for drug screening, and isolating circulating tumor cells, are comprehensively discussed. At the end of this review, current challenges and future development directions of BRMs and UM are highlighted from the perspective of interdisciplinary science.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (2042023ky0080)
This publication has 269 references indexed in Scilit:
- A Novel Model of Urinary Tract Differentiation, Tissue Regeneration, and Disease: Reprogramming Human Prostate and Bladder Cells into Induced Pluripotent Stem CellsEuropean Urology, 2013
- Application of Concave Microwells to Pancreatic Tumor Spheroids Enabling Anticancer Drug Evaluation in a Clinically Relevant Drug Resistance ModelPLOS ONE, 2013
- A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell CarcinomaScience Translational Medicine, 2012
- Stereolithographic Bone Scaffold Design Parameters: Osteogenic Differentiation and Signal ExpressionTissue Engineering Part B: Reviews, 2010
- β-Catenin activation synergizes with PTEN loss to cause bladder cancer formationOncogene, 2010
- Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-κB-Dependent MannerCancer Cell, 2010
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic CancerScience, 2009
- Does Arterial Spin-labeling MR Imaging–measured Tumor Perfusion Correlate with Renal Cell Cancer Response to Antiangiogenic Therapy in a Mouse Model?Radiology, 2009
- Hydrogels as extracellular matrix mimics for 3D cell cultureBiotechnology and Bioengineering, 2009
- Osteoclast differentiation and activationNature, 2003